Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su): A phase-I, open-label study in Japanese adults

por Lal, Himal, Zahaf, Toufik, Heineman, Thomas C.
Publicado 2013

Dimensions and Anatomical Variants of the Foramen Transversarium of Typical Cervical Vertebrae

por Sangari, Santosh Kaur, Dossous, Paul-Michel, Heineman, Thomas, Mtui, Estomih Phillip
Publicado 2015

The genetic landscape of programmed death ligand‐1 (PD‐L1) alterations in head and neck cancer

por Heineman, Thomas E., Widman, Adam, Kuan, Edward C., St John, Maie
Publicado 2017

Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults: A double-blind randomized trial

por Leroux-Roels, Geert, Clément, Frédéric, Vandepapelière, Pierre, Fourneau, Marc, Heineman, Thomas, Dubin, Gary
Publicado 2013

Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly

por Vink, Peter, Shiramoto, Masanari, Ogawa, Masayuki, Eda, Masahiro, Douha, Martine, Heineman, Thomas, Lal, Himal
Publicado 2016

Varicella-Zoster Virus Infection Triggers Formation of an Interleukin-1β (IL-1β)-processing Inflammasome Complex

por Nour, Adel M., Reichelt, Mike, Ku, Chia-Chi, Ho, Min-Yin, Heineman, Thomas C., Arvin, Ann M.
Publicado 2011

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, o...

por Godeaux, Olivier, Kovac, Martina, Shu, Daniel, Grupping, Katrijn, Campora, Laura, Douha, Martine, Heineman, Thomas C., Lal, Himal
Publicado 2017

Sustained Lesion and Shedding Rate Reductions in Genital Herpes Patients 24 Months after Immunization with GEN-003, a Genital Herpes Immunotherapy

por Heineman, Thomas, Mcneil, Lisa K, Oliphant, Thomas, Natenshon, Andrew, Van Wagoner, Nicholas, Flechtner, Jessica B, Hetherington, Seth
Publicado 2017

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: A Phase III, Group-Matc...

por Grupping, Katrijn, Campora, Laura, Douha, Martine, Heineman, Thomas C, Klein, Nicola P, Lal, Himal, Peterson, James, Oostvogels, Lidia
Publicado 2017

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine

por Grupping, Katrijn, Campora, Laura, Douha, Martine, Heineman, Thomas C, Klein, Nicola P, Lal, Himal, Peterson, James, Vastiau, Ilse, Oostvogels, Lidia
Publicado 2017

Safety and pharmacokinetics of docetaxel in combination with pegvorhyaluronidase alfa in patients with non‐small cell lung cancer

por Heineman, Thomas, Baumgart, Megan, Nanavati, Charvi, Gabrail, Nash, Van Wart, Scott A., Mager, Donald E., Maneval, Daniel C., Fathallah, Anas M., Sekulovich, Rose E.
Publicado 2021

1956. Persistence of Immune Response and Safety of an Adjuvanted Recombinant Zoster Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: End-...

por Mrkvan, Tomas, Campora, Laura, Catteau, Grégory, Douha, Martine, Grupping, Katrijn, Herve, Caroline, Kalema, George, Heineman, Thomas, Klein, Nicola P, Lal, Himal, Oostvogels, Lidia, Schuind, Anne
Publicado 2018

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older

por Schwarz, Tino F, Aggarwal, Naresh, Moeckesch, Beate, Schenkenberger, Isabelle, Claeys, Carine, Douha, Martine, Godeaux, Olivier, Grupping, Katrijn, Heineman, Thomas C, Fauqued, Marta Lopez, Oostvogels, Lidia, Van den Steen, Peter, Lal, Himal
Publicado 2017

Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults

por Schwarz, Tino F., Volpe, Stephanie, Catteau, Gregory, Chlibek, Roman, David, Marie Pierre, Richardus, Jan Hendrik, Lal, Himal, Oostvogels, Lidia, Pauksens, Karlis, Ravault, Stephanie, Rombo, Lars, Sonder, Gerard, Smetana, Jan, Heineman, Thomas, Bastidas, Adriana
Publicado 2018

Analysis of a Phase 2b Study of GEN-003, a Genital Herpes Immunotherapy, Showed Significant Reductions in Viral Shedding and Lesion Rate Vs Placebo

por Heineman, Thomas C, Bernstein, David, Wald, Anna, Van Wagoner, Nicholas, Leone, Peter, Mayer, Kenneth, Lucksinger, Gregg, Win, Sandra, Koltun, William, Desai, Nisha, Oliphant, Thomas, Natenshon, Andrew, McNeil, Lisa K, Flechtner, Jessica B, Hetherington, Seth
Publicado 2017

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

por Berkowitz, Elchonon M., Moyle, Graeme, Stellbrink, Hans-Jürgen, Schürmann, Dirk, Kegg, Stephen, Stoll, Matthias, El Idrissi, Mohamed, Oostvogels, Lidia, Heineman, Thomas C., Brockmeyer, Norbert, deJesus, Edwin, Esser, Stefan, Hawkins, Trevor, Lalezari, Jacob, Orkin, Chloe, Schneider, Stefan
Publicado 2015

Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older

por Curran, Desmond, Oostvogels, Lidia, Heineman, Thomas, Matthews, Sean, McElhaney, Janet, McNeil, Shelly, Diez-Domingo, Javier, Lal, Himal, Andrews, Charles, Athan, Eugene, Berglund, Johan, Campora, Laura, de Looze, Ferdinandus, Korhonen, Tiina, Leung, Edward, Levin, Myron, Volpi, Antonio, Johnson, Robert W
Publicado 2019

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial

por Vink, Peter, Delgado Mingorance, Ignacio, Maximiano Alonso, Constanza, Rubio‐Viqueira, Belen, Jung, Kyung Hae, Rodriguez Moreno, Juan Francisco, Grande, Enrique, Marrupe Gonzalez, David, Lowndes, Sarah, Puente, Javier, Kristeleit, Hartmut, Farrugia, David, McNeil, Shelly A., Campora, Laura, Di Paolo, Emmanuel, El Idrissi, Mohamed, Godeaux, Olivier, López‐Fauqued, Marta, Salaun, Bruno, Heineman, Thomas C., Oostvogels, Lidia
Publicado 2019

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

por Cunningham, Anthony L, Heineman, Thomas C, Lal, Himal, Godeaux, Olivier, Chlibek, Roman, Hwang, Shinn-Jang, McElhaney, Janet E, Vesikari, Timo, Andrews, Charles, Choi, Won Suk, Esen, Meral, Ikematsu, Hideyuki, Choma, Martina Kovac, Pauksens, Karlis, Ravault, Stéphanie, Salaun, Bruno, Schwarz, Tino F, Smetana, Jan, Abeele, Carline Vanden, Van den Steen, Peter, Vastiau, Ilse, Weckx, Lily Yin, Levin, Myron J
Publicado 2018

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

por Oostvogels, Lidia, Heineman, Thomas C., Johnson, Robert W., Levin, Myron J., McElhaney, Janet E., Van den Steen, Peter, Zahaf, Toufik, Dagnew, Alemnew F., Chlibek, Roman, Diez-Domingo, Javier, Gorfinkel, Iris S., Hervé, Caroline, Hwang, Shinn-Jang, Ikematsu, Hideyuki, Kalema, George, Lal, Himal, McNeil, Shelly A., Mrkvan, Tomas, Pauksens, Karlis, Smetana, Jan, Watanabe, Daisuke, Weckx, Lily Yin, Cunningham, Anthony L.
Publicado 2019